56.61 USD
+0.01 (+0.02%)
We assign a fundamental rating of 6 out of 10 to UTMD. UTMD was compared to 184 industry peers in the Health Care Equipment & Supplies industry. UTMD gets an excellent profitability rating and is at the same time showing great financial health properties. UTMD is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
UTMD had positive earnings in the past year.
UTMD had a positive operating cash flow in the past year.
UTMD had positive earnings in each of the past 5 years.
In the past 5 years UTMD always reported a positive cash flow from operatings.
1.2 Ratios
UTMD has a better Return On Assets (9.53%) than 92.39% of its industry peers.
UTMD has a better Return On Equity (9.83%) than 86.41% of its industry peers.
With an excellent Return On Invested Capital value of 8.26%, UTMD belongs to the best of the industry, outperforming 84.78% of the companies in the same industry.
UTMD had an Average Return On Invested Capital over the past 3 years of 12.32%. This is above the industry average of 8.82%.
The 3 year average ROIC (12.32%) for UTMD is well above the current ROIC(8.26%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.53% | ||
| ROE | 9.83% | ||
| ROIC | 8.26% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
1.3 Margins
UTMD's Profit Margin of 30.08% is amongst the best of the industry. UTMD outperforms 97.28% of its industry peers.
In the last couple of years the Profit Margin of UTMD has grown nicely.
UTMD has a better Operating Margin (30.78%) than 97.83% of its industry peers.
In the last couple of years the Operating Margin of UTMD has remained more or less at the same level.
The Gross Margin of UTMD (57.10%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of UTMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.78% | ||
| PM (TTM) | 30.08% | ||
| GM | 57.1% |
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UTMD is creating some value.
UTMD has less shares outstanding than it did 1 year ago.
The number of shares outstanding for UTMD has been reduced compared to 5 years ago.
UTMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
UTMD has an Altman-Z score of 32.22. This indicates that UTMD is financially healthy and has little risk of bankruptcy at the moment.
UTMD has a Altman-Z score of 32.22. This is amongst the best in the industry. UTMD outperforms 98.37% of its industry peers.
UTMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 32.22 |
ROIC/WACC0.94
WACC8.81%
2.3 Liquidity
A Current Ratio of 32.06 indicates that UTMD has no problem at all paying its short term obligations.
UTMD has a Current ratio of 32.06. This is amongst the best in the industry. UTMD outperforms 99.46% of its industry peers.
A Quick Ratio of 29.36 indicates that UTMD has no problem at all paying its short term obligations.
UTMD has a Quick ratio of 29.36. This is amongst the best in the industry. UTMD outperforms 99.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 32.06 | ||
| Quick Ratio | 29.36 |
3. Growth
3.1 Past
The earnings per share for UTMD have decreased strongly by -17.30% in the last year.
Measured over the past 5 years, UTMD shows a small growth in Earnings Per Share. The EPS has been growing by 0.16% on average per year.
The Revenue for UTMD has decreased by -12.35% in the past year. This is quite bad
UTMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.70% yearly.
EPS 1Y (TTM)-17.3%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-19.91%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-1.93%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.99, UTMD is valued correctly.
86.96% of the companies in the same industry are more expensive than UTMD, based on the Price/Earnings ratio.
UTMD is valuated rather cheaply when we compare the Price/Earnings ratio to 26.61, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.99 | ||
| Fwd PE | N/A |
4.2 Price Multiples
96.74% of the companies in the same industry are more expensive than UTMD, based on the Enterprise Value to EBITDA ratio.
UTMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. UTMD is cheaper than 95.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.05 | ||
| EV/EBITDA | 6.54 |
4.3 Compensation for Growth
The excellent profitability rating of UTMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)103.01
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.16%, UTMD has a reasonable but not impressive dividend return.
UTMD's Dividend Yield is rather good when compared to the industry average which is at 0.20. UTMD pays more dividend than 97.28% of the companies in the same industry.
UTMD's Dividend Yield is comparable with the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
5.2 History
The dividend of UTMD has a limited annual growth rate of 1.95%.
UTMD has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of UTMD decreased in the last 3 years.
Dividend Growth(5Y)1.95%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
34.80% of the earnings are spent on dividend by UTMD. This is a low number and sustainable payout ratio.
UTMD's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.8%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:UTMD (12/22/2025, 8:18:34 PM)
56.61
+0.01 (+0.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners70.37%
Inst Owner Change0.42%
Ins Owners7.14%
Ins Owner Change-0.27%
Market Cap181.15M
Revenue(TTM)38.63M
Net Income(TTM)11.62M
Analysts0
Price TargetN/A
Short Float %3.43%
Short Ratio8.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
Yearly Dividend1.22
Dividend Growth(5Y)1.95%
DP34.8%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.99 | ||
| Fwd PE | N/A | ||
| P/S | 4.69 | ||
| P/FCF | 13.05 | ||
| P/OCF | 12.8 | ||
| P/B | 1.53 | ||
| P/tB | 1.76 | ||
| EV/EBITDA | 6.54 |
EPS(TTM)3.54
EY6.25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.34
FCFY7.66%
OCF(TTM)4.42
OCFY7.81%
SpS12.07
BVpS36.95
TBVpS32.13
PEG (NY)N/A
PEG (5Y)103.01
Graham Number54.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.53% | ||
| ROE | 9.83% | ||
| ROCE | 9.99% | ||
| ROIC | 8.26% | ||
| ROICexc | 28.34% | ||
| ROICexgc | 51.06% | ||
| OM | 30.78% | ||
| PM (TTM) | 30.08% | ||
| GM | 57.1% | ||
| FCFM | 35.93% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
ROICexc(3y)38.7%
ROICexc(5y)33.39%
ROICexgc(3y)78.49%
ROICexgc(5y)75.65%
ROCE(3y)14.9%
ROCE(5y)14.86%
ROICexgc growth 3Y-5.7%
ROICexgc growth 5Y-2.21%
ROICexc growth 3Y5.77%
ROICexc growth 5Y9.65%
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
F-Score6
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 9.27% | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 95.53% | ||
| Profit Quality | 119.44% | ||
| Current Ratio | 32.06 | ||
| Quick Ratio | 29.36 | ||
| Altman-Z | 32.22 |
F-Score6
WACC8.81%
ROIC/WACC0.94
Cap/Depr(3y)10.06%
Cap/Depr(5y)9.94%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.32%
Profit Quality(3y)119.58%
Profit Quality(5y)135.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-17.3%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-19.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-1.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.61%
EBIT growth 3Y-5.93%
EBIT growth 5Y-2.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.02%
FCF growth 3Y-10.92%
FCF growth 5YN/A
OCF growth 1Y-37.46%
OCF growth 3Y-11.23%
OCF growth 5Y-2.76%
UTAH MEDICAL PRODUCTS INC / UTMD FAQ
What is the ChartMill fundamental rating of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTMD.
What is the valuation status for UTMD stock?
ChartMill assigns a valuation rating of 5 / 10 to UTAH MEDICAL PRODUCTS INC (UTMD). This can be considered as Fairly Valued.
Can you provide the profitability details for UTAH MEDICAL PRODUCTS INC?
UTAH MEDICAL PRODUCTS INC (UTMD) has a profitability rating of 8 / 10.
What is the valuation of UTAH MEDICAL PRODUCTS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 15.99 and the Price/Book (PB) ratio is 1.53.